1.Safa, A, et al. Genetic characteristics of Matlab variants of Vibrio cholerae O1 that are hybrids between classical and El Tor biotypes. Journal of Medical Microbiology 2006; 55: 1563–1569.
2.Ansaruzzaman, M, et al. Cholera in Mozambique, variant of Vibrio cholerae. Emerging Infectious Diseases 2004; 10: 2057–2059.
3.Nair, GB, et al. Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. Journal of Clinical Microbiology 2006; 44: 4211–4213.
4.Safa, A, et al. Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerging Infectious Diseases 2008; 14: 987–988.
5.Nair, GB, et al. Cholera due to altered El Tor strains Vibrio cholerae O1 in Bangladesh. Journal of Clinical Microbiology 2006; 38: 4211–4213.
6.Chin, CS, et al. The origin of the Haitian cholera outbreak strain. New England Journal of Medicine 2011; 364: 33–42.
7.Taneja, N, et al. Outbreaks caused by new variant of V. cholerae O1 El Tor, India. Emerging Infectious Diseases 2009; 15: 352–353.
8.Kumar, P, et al. A large cholera outbreak due to a new cholera toxin variant of the Vibrio cholerae O1 El Tor biotype in Orissa, Eastern India. Journal of Medical Microbiology 2009; 58: 234–238.
9.Pal, BB, et al. Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India. International Journal of Infectious Diseases 2010; 14: 384–389.
10.World, Health Organization. Manual for Laboratory Investigations of Acute Enteric infections, CDD/83.3. Geneva: World Heath Organization, 1987.
11.Bauer, AW, et al. Antibiotic susceptibility testing by a standardized single disc method. American Journal of Clinical Pathology 1996; 45: 493–496.
12.Khuntia, HK, Pal, BB, Chhotray, GP. Quadruplex PCR assay for simultaneous detection of biotype, serotype, toxigenic potential and central regulating factors of Vibrio cholerae. Journal of Clinical Microbiology 2008; 46: 2399–2401.
13.Morita, M, et al. Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiology Immunology 2008; 52: 314–317.
14.Chhotray, GP, et al. Incidence and molecular analysis of V. cholerae associated with cholera outbreak subsequently to the super cyclone in Orissa, India. Epidemiology and Infection 2002; 128: 131–138.
15.Sinha, S, et al. Molecular comparison of toxigenic clinical and non-toxigenic environmental strains of Vibrio cholerae O1 Ogawa isolated during an outbreak of cholera in South India. Indian Journal of Medical Research 2001; 114: 883–889.
16.Goel, AK, et al. Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India. World Journal of Microbiology and Biotechnology 2010; 26: 281–287.
17.Faruque, AS, et al. Emergence of multidrug-resistant strains of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years. Journal of Health Population and Nutrition 2007; 25: 241–243.
18.Garg, P, et al. Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrobial Agents and Chemotherapy 2006; 45: 1605–1606.
19.Krishna, BV, Patil, AB, Chandrasekhar, MR. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India. Transactions of Royal Society of Tropical Medicine and Hygiene 2006; 100: 224–226.
20.Goel, AK, Jiang, SC. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. Infection Genetics and Evolution 2010; 10: 815–819.
21.Jesudason, MV. Change in serotype and appearance of tetracycline resistance in V. cholerae O1 in Vellore, South India. Indian Journal of Medical Microbiology 2006; 24: 152–153.
22.Sabeena, F, et al. In vitro susceptibility of Vibrio cholerae O1 biotype El Tor strains associated with an outbreak of cholera in Kerala, Southern India. Journal of Antimicrobial and Chemotherapy 2001; 47: 361–362.
23.Beaber, JW, Waldor, MK. Identification of operators and promoters that control SXT conjugative transfer. Journal of Bacteriology 2004; 186: 5945–5949.
24.Beaber, JW, Hochhut, B, Waldor, MK. Genomics and functional analysis of SXT, an integrating antibiotic resistance gene transfer elements derived from Vibrio cholerae. Journal of Bacteriology 2002; 184: 4259–4269.
25.Kaper, JB, Morris, JG Jr., Levine, MM. Cholera. Clinical Microbiology Review 1995; 8: 48–86.
26.Waldor, MK, Mekalanos, JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996; 272: 1910–1914.